Commentary on oncolytic viruses: past, present, and future.
Journal Information
Full Title: J Immunother Cancer
Abbreviation: J Immunother Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests: All authors are employed by EpicentRx, which develops the transforming growth factor-beta trap armed oncolytic virus, AdAPT-001, mentioned here."
Funding Disclosure
Evidence found in paper:
"Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025